Next Article in Journal
Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with Glioma
Next Article in Special Issue
Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models
Previous Article in Journal
What Is the Role of Interleukins in Breast Cancer Bone Metastases? A Systematic Review of Preclinical and Clinical Evidence
Previous Article in Special Issue
Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation Status
 
 
Article

Article Versions Notes

Cancers 2019, 11(12), 2019; https://doi.org/10.3390/cancers11122019
Action Date Notes Link
article xml file uploaded 14 December 2019 07:03 CET Original file -
article xml uploaded. 14 December 2019 07:03 CET Update https://www.mdpi.com/2072-6694/11/12/2019/xml
article pdf uploaded. 14 December 2019 07:03 CET Version of Record https://www.mdpi.com/2072-6694/11/12/2019/pdf
article supplementary file uploaded. 14 December 2019 07:03 CET - https://www.mdpi.com/2072-6694/11/12/2019#supplementary
article html file updated 14 December 2019 07:04 CET Original file -
article html file updated 30 December 2019 15:39 CET Update -
article html file updated 14 February 2020 18:42 CET Update -
article html file updated 19 July 2022 21:41 CEST Update https://www.mdpi.com/2072-6694/11/12/2019/html
Back to TopTop